Everything below concerns reverse-phase HPLC. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Updated 2026-02-11. Numbers and descriptions here follow the published literature rather than marketing material.
The compound binds several melanocortin receptor subtypes rather than a single target, with the strongest functional activity reported at MC4R and measurable activity at MC1R, MC3R and MC5R. MC4R populations are dense in hypothalamic nuclei that integrate energy balance, autonomic tone and reproductive behaviour, which is the anatomical basis for the proposed pro-desire effect. Because binding is not subtype-selective, pigmentary and vascular effects accompany central activity. Improving subtype selectivity is an active area of analogue design. Direct causal mapping from receptor occupancy to reported desire change in humans is not fully established.
After subcutaneous dosing, peak plasma concentrations appear within roughly one hour, and elimination is fast, with a half-life on the order of a few hours. Degradation is mainly proteolytic, and at least one circulating fragment retains receptor activity, so parent-drug levels alone do not describe total exposure. Clearance does not depend heavily on hepatic cytochrome enzymes, which lowers the likelihood of common metabolic interaction routes. Data in renal or hepatic impairment are limited. Repeated dosing does not appear to produce marked accumulation given the short half-life.
Bremelanotide acts as an agonist at several melanocortin receptors, with the strongest reported activity at MC4R and measurable activity at MC1R and MC3R. Because MC4R is expressed in hypothalamic and limbic circuits, the proposed mechanism links receptor activation to modulation of central pathways involved in desire rather than to direct effects on peripheral genital tissue. The precise downstream steps remain incompletely characterized, and evidence for the involvement of specific neurotransmitters is suggestive rather than settled. Nausea and blood pressure elevation reported during trials are consistent with melanocortin signaling outside the intended target circuit.
Compared with melanotan II, bremelanotide is a smaller cyclic peptide with a more constrained backbone, which affects receptor selectivity and metabolic stability. Published descriptions give a plasma half-life on the order of a few hours after subcutaneous administration, with elimination through hepatic and renal routes and limited plasma protein binding. Central access is inferred from effects observed in animal models, although direct measurement in humans is limited. Handling and storage requirements follow from the peptide backbone, which is susceptible to hydrolysis and oxidation.
The melanocortin system comprises five G protein-coupled receptors, designated MC1 through MC5, that signal mainly through cyclic AMP accumulation. MC1R and MC2R are associated with pigmentation and adrenal steroid production, while MC3R and MC4R are expressed in the central nervous system and influence energy balance and behavior. MC5R appears in exocrine tissues. Natural agonists include alpha-melanocyte-stimulating hormone and adrenocorticotropic hormone, and endogenous antagonists such as agouti-related protein modulate the same sites. This receptor family provides the framework within which bremelanotide activity is described.
| Property | Value | Notes |
|---|---|---|
| Primary target | MC4R | Highest reported functional activity |
| Peak plasma time | About 1 hour | Subcutaneous administration |
| Elimination half-life | A few hours | Active fragment may extend effect |
| Main clearance route | Proteolytic degradation | Not cytochrome-dependent |
| Typical assay | LC-MS/MS | Plasma quantification |
Certificate of analysis documents usually report purity percentage, molecular weight, and appearance. Researchers verify identity by comparing observed and theoretical mass values. Chain-of-custody records and batch numbers help trace material from source to experiment. Independent verification of supplier claims is considered good practice when material identity is critical to a study. Records should include the storage history of each aliquot, and unexpected deviations in appearance or solubility warrant re-testing before use.
Lyophilized peptide material is generally stored at -20 °C or below to limit degradation, while reconstituted solutions are less stable and are typically kept refrigerated and protected from light. Repeated freeze-thaw cycles can accelerate aggregation and should be minimized. Stability for any specific lot depends on purity, moisture content, and packaging. Handling in a temperature-controlled environment reduces variability across replicates, and exposure to ambient humidity during weighing can introduce error. Aliquotting reduces the number of times a stock container is opened.
Reverse-phase high-performance liquid chromatography is the standard method for assessing purity. Mass spectrometry confirms molecular identity and detects sequence variants or truncation products. Ultraviolet absorbance at 214 or 280 nm is used for quantification, with the choice depending on the peptide sequence. Method validation typically addresses linearity, limit of detection, and precision across a defined concentration range. Impurity profiling may also employ ion-exchange or size-exclusion chromatography, and these techniques complement one another.
Reconstitution is usually performed with sterile water or a dilute acetic acid solution, and the choice of solvent affects both dissolution speed and final pH. Complete dissolution should be confirmed by visual inspection before any aliquot is taken, since undissolved particles can concentrate in the sampling volume. Repeated freeze-thaw cycles are the most common cause of gradual loss of purity, so dividing a stock into single-use aliquots at the first opportunity is standard practice. Working solutions kept refrigerated are generally used within days rather than weeks.
Identity and purity are established with orthogonal methods rather than a single test. Reverse-phase high-performance liquid chromatography with ultraviolet detection gives a purity figure by area normalization, while mass spectrometry confirms the expected molecular ion. Amino acid analysis or peptide mapping can detect sequence errors that a mass value alone would miss, and residual counterion content is sometimes measured separately. Common impurities include truncated sequences, oxidized residues, and deamidated products; reporting them individually is more informative than a single composite purity number.
Bremelanotide is a synthetic cyclic heptapeptide developed as an analogue of alpha-melanocyte-stimulating hormone, a naturally occurring peptide involved in pigmentation and appetite signalling. Its structure contains seven amino acid residues joined by a lactam bridge that closes the ring between two side chains. The molecular formula is C50H68N14O10 and the nominal molecular mass is near 1025 daltons. Much of the early laboratory literature refers to the same molecule by the development code PT-141.
The compound emerged from a research programme examining melanocortin analogues for effects on skin pigmentation. During early human studies, participants reported spontaneous erections as an unexpected side effect, which redirected development toward sexual function rather than tanning. An intranasal formulation was investigated in clinical trials but did not reach market approval. A subcutaneous injectable version later completed the regulatory process, and the nasal route does not appear in approved labelling.
PT-141 is the original development code for bremelanotide, a synthetic peptide first studied as a potential tanning and sexual-response agent in the 1990s. Researchers at a small American biotechnology firm designed it as a shortened analogue of melanotan II, which itself came from work on alpha-melanocyte-stimulating hormone. Early screening focused on pigmentation, but behavioural observations in animal models redirected attention toward sexual motivation. That shift made PT-141 one of the first melanocortin compounds investigated specifically for effects on desire rather than on skin colour.
Clinical development proceeded through two routes of administration. An intranasal formulation advanced first, but variable absorption and tolerability problems led to a switch to subcutaneous injection. The United States Food and Drug Administration approved the subcutaneous product in 2019 for hypoactive sexual desire disorder in premenopausal women. Marketing rights subsequently changed hands, and commercial availability has fluctuated since approval. Use in men, in postmenopausal women, and in combination with other agents remains outside the approved label.
Outside the approved product, bremelanotide circulates as a research chemical sold by peptide vendors, often labelled PT-141. Such material is not manufactured under pharmaceutical quality standards, and independent testing has repeatedly found content that differs from the label. Analytical certificates supplied with a purchase are not strong evidence of purity because they are usually generated by the seller. Online discussion tends to blur the distinction between the approved drug and unregulated powder, which complicates interpretation of reported experiences.
== SO == so – (s) Somali language (ISO 639-1 code) SO (i) Shared Object (Unix) Sheriff's Office Significant other (s) Somalia (ISO 3166 and FIPS 10-4 country code digram) SOA (a) service-oriented architecture (a) Society of Actuaries (i) State of the art SOAP (a) Simple Object Access Protocol Supplemental Offer and Acceptance Program (U.S. medical residency matching) SOB (i) Son Of a Bitch Same Old Bullshit SOC – (a) Sector Operations Centre Soccsksargen – (p) South Cotabato, Cotabato, Sultan Kudarat, Sarangani, General Santos (a region in the Philippines; pronounced "sock-sar-gen") SOCOM – (p) (U.S.) Special Operations Command SoCon – (p) Southern Conference (U.S.
Donated blood is usually processed after collection to make it suitable for use in specific patient populations. Collected blood is then separated into blood components by centrifugation: red blood cells, plasma, and platelets. Plasma can be further processed to manufacture albumin protein, clotting factor concentrates, cryoprecipitate, fibrinogen concentrate, and immunoglobulins (antibodies). Red cells, plasma, and platelets can also be donated individually via a more complex process called apheresis. Different blood components require specific storage conditions: red blood cells are typically stored at 1–6 °C, platelets at 20–24 °C with continuous agitation, and plasma is stored frozen at −18 °C or lower to preserve clotting factors.
== External links == Lesch-Nyhan Syndrome at NIH's Office of Rare Diseases GeneReview/NIH/UW entry on Lesch–Nyhan syndrome National Institute of Child Health and Human Development (NICHD) Love Never Sinks • Lesch Nyhan• Patient Advocacy Group
== Virginia House of Delegates == In 2005, Wittman was elected to the Virginia House of Delegates, representing the 99th district. He served on the Agricultural; Chesapeake and Natural Resources; and Police and Public Safety Committees.
Sources: en.wikipedia.org
=== Feedback inhibition === In some multienzyme systems, the enzyme is inhibited by the end product whenever its concentration is above the requirements of the cell. So, the velocity of the reaction can be controlled by the amount of product that is needed by the cell (the lower the requirement is, the slower the reaction goes). Feedback inhibition is one of the most important function of proteins. Due to feedback inhibition, a cell is able to know whether the amount of a product is enough for its subsistence or there is a lack of the product (or there is too much product). The cell is able to react to this kind of situation in a mechanical way and solve the problem of the amount of a product. An example of feedback inhibition in human cells is the protein aconitase (an enzyme that catalyses the isomeration of citrate to isocitrate). When the cell needs iron, this enzyme loses the iron molecule and its form changes. When this happens, the aconitase is converted to IRPF1, a translation repressor or mRNA stabilizer that represses the formation of iron-binding proteins and favours formation of proteins that can get iron from the cell's reservations
== International expansion == In a partnership with Persian Gulf company Alghanim Industries, the first international Slim Chickens opened in Salmiya, Kuwait, in May 2017. This location has since closed in 2022. The first UK location opened in London at 35 James Street in March 2018 via a partnership with Boparan Restaurant Group. A Cardiff branch opened in St David's 2 shopping centre in 2019. A Bristol branch opened in 2019 in the shopping area of Cabot Circus. A branch of this restaurant chain opened in Birmingham. The first branch in Kent, England, opened in Bluewater Shopping Centre in February 2020. In 2021, branches were opened in Bournemouth, Southampton and Plymouth. In 2023, branches in Bury St Edmunds and Crawley opened. As of May 2026, there are currently over 70 branches open in the UK. The first Turkish location opened on July 23rd, 2023 at Istanbul Airport. The first German location opened August 24, 2024 in Berlin. Meanwhile, the first Malaysian location opened July 15, 2025 in Subang Jaya.
== Freedom == Freedom House's Freedom in the World 2019 ranked Thailand "not free". Its 2019 score declined from the previous year. The study scored 195 nations and 14 territories. In ASEAN, Indonesia ranked number one, but was only ranked "partly free". Other ASEAN nations were ranked in this order from top to bottom: "Partly free": Philippines; Malaysia; Singapore; Myanmar. "Not free": Thailand; Brunei; Cambodia; Vietnam; Laos. Freedom House, in its report, Freedom in the World 2018, ranked Thailand as "not free". Of the 210 countries ranked, Thailand was ranked 156 (1=most free; 210=least free). Other ASEAN nations ranked were: Indonesia, 98; Philippines, 105; Singapore, 124; Malaysia, 134; Myanmar, 154; Cambodia, 158; Brunei, 161; Vietnam, 178; Laos, 193. Freedom House, in its Freedom in the World 2015 report, reduced Thailand's previous ranking of "partly free" to "not free", making it one of 51 nations and territories in that category.
In the process prior to filling and sealing, individual bottles are always rinsed with deionised water to remove any particles that could cause a change in taste. Deionised and distilled water are used in lead–acid batteries to prevent erosion of the cells, although deionised water is the better choice as more impurities are removed from the water in the creation process.
Additionally, PELs lack the inherent amplification capabilities of DELs and rely on current mass spectrometric analysis for decoding. Since peptide decoding requires complex mass spectrometry and computational power, this means that current detection sensitivity limits practical PEL sizes.
Sources: en.wikipedia.org
MC4R is regarded as the primary mediator on the basis of binding and functional assays. Other subtypes are also engaged, which helps explain flushing and related side effects. The step from receptor activation to reported desire change remains partly inferential.
Elimination is rapid, with a half-life of a few hours. An active fragment circulates after breakdown, so biological activity may outlast measurable parent drug. This is one reason single-timepoint measurements are limited.
Because breakdown is mainly proteolytic rather than cytochrome-dependent, classic metabolic interactions are less likely. Agents affecting blood pressure could still matter. Formal interaction studies are sparse.
Reported activity is highest at MC4R, with lower potency at MC1R and MC3R. The MC4R interaction is generally treated as the most relevant to its central effects. Selectivity is not absolute, and activity across the family is dose-dependent.